Britannia Life Sciences Announces Growth and Expansion
Company Announcements

Britannia Life Sciences Announces Growth and Expansion

Story Highlights

Britannia Life Sciences Inc (TSE:BLAB) has released an update.

Britannia Life Sciences Inc. has reported a revenue increase to $7.6 million and an adjusted EBITDA of $1.7 million for fiscal year 2024. The company also highlighted the strategic launch of its PhotonAssayTM units in Ontario and British Columbia, as well as a successful private placement raising $932,000, signaling expansion and technological advancements in mineral analysis.

For further insights into TSE:BLAB stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskBritannia Life Sciences Launches Strategic Financing Drive
TipRanks Canadian Auto-Generated NewsdeskBritannia Life Sciences Back on Track with OSC
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App